New Anticoagulant Pill Works Well in Trial

By Steven Reinberg
HealthDay Reporter

(HealthDay News) -- The new anti-clotting pill rivaroxaban (Xarelto) lowers the risk of stroke, heart attack and death in patients who have had a heart attack or suffer from unstable angina, a new trial shows.

Rivaroxaban is a pill that blocks factor Xa, which is involved in blood clotting. In earlier studies, the drug was effective in

Read more

What Is an ECG?

An electrocardiogram, also known as an ECG or EKG, records the heart's electrical signals to determine whether the pattern is normal. Learn more about electrical signals in the heart and how ECGs work.

What Is an ECG?

Read more